Rep. April McClain Delaney Purchases Shares of BWX Technologies, Inc. (NYSE:BWXT)

Representative April McClain Delaney (Democratic-Maryland) recently bought shares of BWX Technologies, Inc. (NYSE:BWXT). In a filing disclosed on June 05th, the Representative disclosed that they had bought between $15,001 and $50,000 in BWX Technologies stock on May 8th.

Representative April McClain Delaney also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Hubbell (NYSE:HUBB) on 5/29/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of Martin Marietta Materials (NYSE:MLM) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of Hubbell (NYSE:HUBB) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of EMCOR Group (NYSE:EME) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of Viking (NYSE:VIK) on 5/28/2026.
• Purchased $1,001 – $15,000 in shares of C.H. Robinson Worldwide (NASDAQ:CHRW) on 5/28/2026.
• Sold $1,001 – $15,000 in shares of Viking (NYSE:VIK) on 5/27/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/27/2026.
• Sold $1,001 – $15,000 in shares of Tractor Supply (NASDAQ:TSCO) on 5/26/2026.

BWX Technologies Trading Up 0.7%

Shares of NYSE BWXT traded up $1.29 during trading on Tuesday, hitting $188.75. 1,019,471 shares of the company were exchanged, compared to its average volume of 1,029,432. BWX Technologies, Inc. has a 12-month low of $128.96 and a 12-month high of $241.82. The company has a debt-to-equity ratio of 1.58, a quick ratio of 2.33 and a current ratio of 2.40. The company has a fifty day moving average price of $210.54 and a 200-day moving average price of $199.78. The firm has a market capitalization of $17.29 billion, a PE ratio of 50.47, a P/E/G ratio of 3.06 and a beta of 0.73.

BWX Technologies (NYSE:BWXT) last posted its quarterly earnings results on Monday, May 4th. The technology company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.92 by $0.20. BWX Technologies had a return on equity of 31.33% and a net margin of 10.20%.The business had revenue of $860.22 million for the quarter, compared to analyst estimates of $837.47 million. During the same quarter in the previous year, the firm earned $0.91 EPS. The company’s quarterly revenue was up 26.1% compared to the same quarter last year. BWX Technologies has set its FY 2026 guidance at 4.600-4.750 EPS. As a group, equities research analysts expect that BWX Technologies, Inc. will post 4.71 EPS for the current year.

BWX Technologies Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, June 5th. Stockholders of record on Tuesday, May 19th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Tuesday, May 19th. BWX Technologies’s payout ratio is currently 28.88%.

Insider Transactions at BWX Technologies

In other news, CEO Rex D. Geveden sold 10,000 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total transaction of $2,048,100.00. Following the completion of the transaction, the chief executive officer directly owned 202,491 shares of the company’s stock, valued at approximately $41,472,181.71. The trade was a 4.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the transaction, the chief financial officer directly owned 6,884 shares of the company’s stock, valued at approximately $1,440,477. This represents a 25.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. BTIG Research lifted their price target on BWX Technologies from $225.00 to $235.00 and gave the stock a “buy” rating in a report on Thursday, February 26th. TD Cowen started coverage on shares of BWX Technologies in a report on Thursday, March 12th. They issued a “buy” rating and a $230.00 price objective on the stock. Zacks Research lowered shares of BWX Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Weiss Ratings restated a “buy (b-)” rating on shares of BWX Technologies in a report on Friday, May 22nd. Finally, Wells Fargo & Company started coverage on shares of BWX Technologies in a report on Wednesday, April 1st. They issued an “underweight” rating and a $200.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $228.00.

Institutional Trading of BWX Technologies

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Optiver Holding B.V. purchased a new stake in BWX Technologies during the first quarter worth about $175,000. First Nebraska Trust Co purchased a new stake in BWX Technologies during the first quarter worth about $307,000. Segall Bryant & Hamill LLC purchased a new stake in BWX Technologies during the first quarter worth about $4,461,000. BankChampaign National Association purchased a new stake in BWX Technologies during the first quarter worth about $645,000. Finally, Western Wealth Management LLC increased its stake in BWX Technologies by 4.7% during the first quarter. Western Wealth Management LLC now owns 6,309 shares of the technology company’s stock worth $1,290,000 after purchasing an additional 285 shares during the period. 94.39% of the stock is currently owned by hedge funds and other institutional investors.

About Representative McClain Delaney

April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.

April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.

BWX Technologies Company Profile

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.